title: Sensitizing and protective substances in radiation therapy and predictive assays.
abstract: In an investigation by the Swedish Cancer Society, an expert group described the present status, critical issues and future aspects and potentials for each of nine major areas of radiation therapy research. The present report deals with the use of sensitizing and protective substances in radiation therapy and predictive assays on normal tissues and tumour response.
authors.affiliation: From the Department of Oncology, Umea University, Umea (B. Zackrisson, B. Littbrand),Department of Oncology, University Hospital, Lund (E. Kjellen), Department of Oncology, Radiology and Clinical Immunology, University Hospital, Uppsala (B. Glimelius, J. Carlsson, I. Turesson) and Radiumhemmet, Karolinska Institutet, Stockholm (B. Glimelius), Sweden.
authors.forename: Björn
authors.initials: B
authors.lastname: Zackrisson
authors.affiliation: From the Department of Oncology, Umea University, Umea (B. Zackrisson, B. Littbrand),Department of Oncology, University Hospital, Lund (E. Kjellen), Department of Oncology, Radiology and Clinical Immunology, University Hospital, Uppsala (B. Glimelius, J. Carlsson, I. Turesson) and Radiumhemmet, Karolinska Institutet, Stockholm (B. Glimelius), Sweden.
authors.forename: Elisabeth
authors.initials: E
authors.lastname: Kjellén
authors.affiliation: From the Department of Oncology, Umea University, Umea (B. Zackrisson, B. Littbrand),Department of Oncology, University Hospital, Lund (E. Kjellen), Department of Oncology, Radiology and Clinical Immunology, University Hospital, Uppsala (B. Glimelius, J. Carlsson, I. Turesson) and Radiumhemmet, Karolinska Institutet, Stockholm (B. Glimelius), Sweden.
authors.forename: Bengt
authors.initials: B
authors.lastname: Glimelius
authors.affiliation: From the Department of Oncology, Umea University, Umea (B. Zackrisson, B. Littbrand),Department of Oncology, University Hospital, Lund (E. Kjellen), Department of Oncology, Radiology and Clinical Immunology, University Hospital, Uppsala (B. Glimelius, J. Carlsson, I. Turesson) and Radiumhemmet, Karolinska Institutet, Stockholm (B. Glimelius), Sweden.
authors.forename: Jörgen
authors.initials: J
authors.lastname: Carlsson
authors.affiliation: From the Department of Oncology, Umea University, Umea (B. Zackrisson, B. Littbrand),Department of Oncology, University Hospital, Lund (E. Kjellen), Department of Oncology, Radiology and Clinical Immunology, University Hospital, Uppsala (B. Glimelius, J. Carlsson, I. Turesson) and Radiumhemmet, Karolinska Institutet, Stockholm (B. Glimelius), Sweden.
authors.forename: Bo
authors.initials: B
authors.lastname: Littbrand
authors.affiliation: From the Department of Oncology, Umea University, Umea (B. Zackrisson, B. Littbrand),Department of Oncology, University Hospital, Lund (E. Kjellen), Department of Oncology, Radiology and Clinical Immunology, University Hospital, Uppsala (B. Glimelius, J. Carlsson, I. Turesson) and Radiumhemmet, Karolinska Institutet, Stockholm (B. Glimelius), Sweden.
authors.forename: Ingela
authors.initials: I
authors.lastname: Turesson
authors.affiliation: From the Department of Oncology, Umea University, Umea (B. Zackrisson, B. Littbrand),Department of Oncology, University Hospital, Lund (E. Kjellen), Department of Oncology, Radiology and Clinical Immunology, University Hospital, Uppsala (B. Glimelius, J. Carlsson, I. Turesson) and Radiumhemmet, Karolinska Institutet, Stockholm (B. Glimelius), Sweden.
mesh_terms: D015687:Cell Hypoxia; D006801:Humans; D009369:Neoplasms / Q000532:radiotherapy*; D011237:Predictive Value of Tests; D011835:Radiation Protection / Q000379:methods*; D011837:Radiation-Protective Agents / Q000627:therapeutic use*; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use*
chemical_list: D011837:Radiation-Protective Agents; D011838:Radiation-Sensitizing Agents